Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2026-02-25 @ 8:58 PM
Study NCT ID:
NCT02551718
Status:
COMPLETED
Last Update Posted:
2022-06-30
First Post:
2015-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
Sponsor:
University of Washington
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Acute Leukemia of Ambiguous Lineage | View |
| None | Recurrent Acute Lymphoblastic Leukemia | View |
| None | Recurrent Acute Myeloid Leukemia | View |
| None | Refractory Acute Lymphoblastic Leukemia | View |
| None | Refractory Acute Myeloid Leukemia | View |
| None | Refractory Acute Leukemia of Ambiguous Lineage | View |
Keywords: